Abbott buys rest of diagnostic systems maker

(AP) — Abbott Laboratories paid $175 million to buy the remaining stake in Ibis Biosciences Inc. from Isis Pharmaceuticals Inc., the companies said Wednesday. Earlier this year, Abbott invested $40 million for a minority stake in Ibis, a Carlsbad, Calif., maker of molecular diagnostic systems ...

Read More

Copyright CRAIN - Crain's
Contact Us